(2024). ASA vs. Clopidogrel vs. Oral Anticoagulant After Interventional Transcatheter Mitral Valve Replacement: A Pooled Network Meta-analysis. test, 8(2), -. doi: 10.21608/cvrepj.2024.400090
. "ASA vs. Clopidogrel vs. Oral Anticoagulant After Interventional Transcatheter Mitral Valve Replacement: A Pooled Network Meta-analysis". test, 8, 2, 2024, -. doi: 10.21608/cvrepj.2024.400090
(2024). 'ASA vs. Clopidogrel vs. Oral Anticoagulant After Interventional Transcatheter Mitral Valve Replacement: A Pooled Network Meta-analysis', test, 8(2), pp. -. doi: 10.21608/cvrepj.2024.400090
ASA vs. Clopidogrel vs. Oral Anticoagulant After Interventional Transcatheter Mitral Valve Replacement: A Pooled Network Meta-analysis. test, 2024; 8(2): -. doi: 10.21608/cvrepj.2024.400090

ASA vs. Clopidogrel vs. Oral Anticoagulant After Interventional Transcatheter Mitral Valve Replacement: A Pooled Network Meta-analysis

Cardiovascular Research Prove Journal
Volume 8, Issue 2, December 2024    PDF (1.25 M)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2024.400090
Abstract
Mitral valve diseases, increasingly common with 
age, present challenges for valve replacement 
surgeries. Bioprosthetic valves and transcatheter 
mitral valve replacement (TMVR) offer 
alternatives, yet optimal post-surgery 
anticoagulant strategies remain unclear. Studies 
comparing warfarin, aspirin, and direct oral 
anticoagulants (DOACs) show mixed results.
Statistics
Article View: 49
PDF Download: 42